Margaret Lee, PhD
Zalicus Inc · Zalicus, Inc. · Zalicus
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Margaret Lee, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:58 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT01655849 · Phase 2 Efficacy Trial of Z160 in Lumbosacral RadiculopathyZalicus · completed · Lumbosacral Radiculopathy · study director
- Ph2NCT01369745 · A Phase II Trial Comparing Z-102 With Placebo In Patients With Moderate To Severe Rheumatoid ArthritisZalicus · completed · Rheumatoid Arthritis · study director
- Ph2NCT00747214 · A Study Comparing CRx-102 Plus Disease-modifying Anti-rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in RAZalicus · completed · Rheumatoid Arthritis · study director
- Ph2NCT00551707 · Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid ArthritisZalicus · completed · Rheumatoid Arthritis · study director
- Ph2NCT00521989 · CRx-102 Osteoarthritis Multicenter Evaluation TrialZalicus · terminated · Knee Osteoarthritis · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:58 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.